Ariad Pharmaceuticals (ARIA) 8.13 $ARIA Seeking
Post# of 64200
Posted On: 02/28/2015 7:27:47 PM
Ariad Pharmaceuticals (ARIA) 8.13 $ARIA
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.71 (-0.25), VRX: 197.48 (-3.77), ACT: 291.36 (+1.58), PCYC: 215.93 (-1.89), MDT: 77.59 (-1.22), CAH: 87.99 (-0.18), CLDX: 25.54 (+0.60), HSP: 87.54 (unch), AGN: 232.74 (+0.34), JNJ: 102.51 (-0.29), ATOS: 1.92 (-0.07), ONVO: 5.92 (-0.14), PTCT: 71.33 (-2.13), SNY: 48.86 (-0.01), PTLA: 38.08 (-0.56), INCY: 85.85 (-1.69), PFE: 34.32 (-0.27), CPHR: 11.51 (-1.43), MYL: 57.33 (+0.09), AMGN: 157.72 (-1.25), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54), MNKD: 6.52 (-0.30), NKTR: 13.07 (+0.09), OMER: 20.87 (-0.06), DVA: 74.60 (+0.30), GILD: 103.53 (-0.66), SGEN: 36.25 (-0.18), ACHN: 12.14 (-0.35), MRK: 58.54 (-0.42), TEVA: 57.02 (+0.53), BIL: 45.73 (+0.01), ARIA: 8.13 (-0.04), NVS: 102.40 (-0.60)
What Sarissa Capital's Proxy Fight Means For Ariad Investors
Investing Healthcare - at Seeking Alpha - Mon Feb 23, 7:53AM CST
AMRN: 1.51 (+0.05), VVUS: 2.61 (-0.08), ARIA: 8.13 (-0.04)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
PATK: 55.25 (-0.75), TILE: 20.19 (+0.11), DISCB: 34.90 (-0.10), DISCA: 32.30 (-0.14), CCRN: 12.96 (-0.04), EGLT: 15.01 (+0.03), DISCK: 30.51 (-0.33), PRQR: 18.83 (-0.94), AMOT: 27.86 (-0.04), ATRO: 69.56 (+1.51), ASMB: 13.51 (-0.94), ARIA: 8.13 (-0.04), UNTD: 16.37 (+0.16), WSCI: 6.06 (-0.04), SZMK: 7.90 (+0.01)
Most active Nasdaq-traded stocks
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 30.67 (+0.05), FB: 78.97 (-1.44), DISCB: 34.90 (-0.10), DISCA: 32.30 (-0.14), INTC: 33.25 (-0.40), DISCK: 30.51 (-0.33), MRVL: 16.12 (+0.02), AMAT: 25.05 (+0.14), ODP: 9.37 (+0.07), ARIA: 8.13 (-0.04), MSFT: 43.85 (-0.21), ZNGA: 2.30 (-0.01), AAPL: 128.46 (-1.95), CSCO: 29.51 (-0.40)
Arista and Noodles are big market movers
AP - Fri Feb 20, 4:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FUEL: 9.77 (-0.19), NDLS: 18.23 (-0.63), ARIA: 8.13 (-0.04)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 409.59 (-0.51), BMRN: 107.07 (-1.77), CVM: 1.04 (+0.08), MDGN: 7.84 (-0.23), PFE: 34.32 (-0.27), SGMO: 16.82 (-0.15), RPRX: 9.21 (-0.28), MNKD: 6.52 (-0.30), CELG: 121.53 (-1.82), SGEN: 36.25 (-0.18), TEVA: 57.02 (+0.53), ARIA: 8.13 (-0.04), SNY: 48.86 (-0.01), REGN: 413.84 (-6.03)
Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 2:38PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: After reporting fourth quarter and full...
ARIA: 8.13 (-0.04)
Ariad's largest shareholder starts proxy fight to oust CEO
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:12AM CST
VVUS: 2.61 (-0.08), ARIA: 8.13 (-0.04)
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
at The Street - Fri Feb 20, 6:09AM CST
Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 1:41PM CST
ARIA: 8.13 (-0.04)
Ariad Pharmaceuticals ups revenues 695% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 8:22AM CST
ARIA: 8.13 (-0.04)
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:05AM CST
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss
ARIA: 8.13 (-0.04)
Ariad reports 4Q loss
Automated Insights - Thu Feb 19, 7:43AM CST
CAMBRIDGE, Mass. (AP) _ Ariad Pharmaceuticals Inc. (ARIA) on Thursday reported a loss of $5.8 million in its fourth quarter.
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals (ARIA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 19, 7:25AM CST
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:39AM CST
ARIA: 8.13 (-0.04)
ARIAD Reports 2014 Financial Results, Provides 2015 Financial Guidance and Outlines Strategic Objectives
Business Wire - Thu Feb 19, 6:35AM CST
--Three New Iclusig Clinical Trials Planned to Begin This Year
ARIA: 8.13 (-0.04)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 4:30PM CST
NBL: 47.23 (-0.09), TTC: 67.65 (+0.12), HST: 21.00 (-0.12), LXP: 10.83 (+0.12), UPL: 16.27 (+0.05), BBW: 21.67 (+0.72), WMT: 83.93 (+0.13), PDCO: 50.08 (+0.64), IDA: 62.62 (-0.22), CVRR: 19.46 (+0.94), DAN: 21.85 (-0.17), AYR: 23.07 (+0.13), DNR: 8.40 (+0.02), HII: 141.33 (-1.31), PWR: 28.78 (-0.08), GEL: 46.00 (+0.86), HRL: 58.51 (+0.05), MTRN: 36.62 (-0.32), UAN: 14.02 (+0.19), PCLN: 1,237.48 (-3.77), BCC: 35.61 (-0.25), ANIP: 67.36 (-2.10), NM: 4.35 (-0.24), SGNT: 27.18 (-1.16), IDCC: 52.87 (+0.19), BLMN: 25.76 (+0.40), PDCE: 51.68 (-1.99), DAVE: 30.72 (+0.06), WST: 54.72 (-0.23), TK: 44.24 (+0.17), VNDA: 10.76 (-0.28), CVI: 41.99 (+0.77), CLI: 18.81 (-0.17), CCC: 20.63 (-0.14), FCN: 36.87 (-0.26), IRC: 10.70 (+0.19), DTV: 88.60 (+0.25), AGI: 6.05 (-0.13), LINE: 12.02 (+0.06), SCG: 56.95 (-0.07), DISCA: 32.30 (-0.14), CBB: 3.35 (-0.01), IMAX: 34.97 (-0.04), RS: 57.01 (-0.53), SYNT: 49.40 (-0.23), DWRE: 63.19 (-1.36), FUN: 55.93 (+0.25), ATRO: 69.56 (+1.51), ARIA: 8.13 (-0.04), LPLA: 44.86 (-0.11), ACTA: 16.76 (+0.29), BRC: 26.96 (-0.22), GG: 21.98 (+0.24)
Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:40AM CST
ARIAD Pharmaceuticals (ARIA) is set to report fourth-quarter 2014 results on Feb 19.
IPXL: 40.29 (-0.41), ISIS: 68.56 (+1.23), HZNP: 20.53 (+1.46), ARIA: 8.13 (-0.04)
Seeking Alpha's Biotech Weekly: Achillion Overdone, Sanofi's Toujeo A Go, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 27, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
CYTK: 7.71 (-0.25), VRX: 197.48 (-3.77), ACT: 291.36 (+1.58), PCYC: 215.93 (-1.89), MDT: 77.59 (-1.22), CAH: 87.99 (-0.18), CLDX: 25.54 (+0.60), HSP: 87.54 (unch), AGN: 232.74 (+0.34), JNJ: 102.51 (-0.29), ATOS: 1.92 (-0.07), ONVO: 5.92 (-0.14), PTCT: 71.33 (-2.13), SNY: 48.86 (-0.01), PTLA: 38.08 (-0.56), INCY: 85.85 (-1.69), PFE: 34.32 (-0.27), CPHR: 11.51 (-1.43), MYL: 57.33 (+0.09), AMGN: 157.72 (-1.25), LLY: 70.17 (+0.14), BMY: 60.92 (-0.54), MNKD: 6.52 (-0.30), NKTR: 13.07 (+0.09), OMER: 20.87 (-0.06), DVA: 74.60 (+0.30), GILD: 103.53 (-0.66), SGEN: 36.25 (-0.18), ACHN: 12.14 (-0.35), MRK: 58.54 (-0.42), TEVA: 57.02 (+0.53), BIL: 45.73 (+0.01), ARIA: 8.13 (-0.04), NVS: 102.40 (-0.60)
What Sarissa Capital's Proxy Fight Means For Ariad Investors
Investing Healthcare - at Seeking Alpha - Mon Feb 23, 7:53AM CST
AMRN: 1.51 (+0.05), VVUS: 2.61 (-0.08), ARIA: 8.13 (-0.04)
Nasdaq stocks posting largest percentage increases
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
PATK: 55.25 (-0.75), TILE: 20.19 (+0.11), DISCB: 34.90 (-0.10), DISCA: 32.30 (-0.14), CCRN: 12.96 (-0.04), EGLT: 15.01 (+0.03), DISCK: 30.51 (-0.33), PRQR: 18.83 (-0.94), AMOT: 27.86 (-0.04), ATRO: 69.56 (+1.51), ASMB: 13.51 (-0.94), ARIA: 8.13 (-0.04), UNTD: 16.37 (+0.16), WSCI: 6.06 (-0.04), SZMK: 7.90 (+0.01)
Most active Nasdaq-traded stocks
AP - Fri Feb 20, 5:00PM CST
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
MU: 30.67 (+0.05), FB: 78.97 (-1.44), DISCB: 34.90 (-0.10), DISCA: 32.30 (-0.14), INTC: 33.25 (-0.40), DISCK: 30.51 (-0.33), MRVL: 16.12 (+0.02), AMAT: 25.05 (+0.14), ODP: 9.37 (+0.07), ARIA: 8.13 (-0.04), MSFT: 43.85 (-0.21), ZNGA: 2.30 (-0.01), AAPL: 128.46 (-1.95), CSCO: 29.51 (-0.40)
Arista and Noodles are big market movers
AP - Fri Feb 20, 4:34PM CST
NEW YORK (AP) — Stocks that moved substantially or traded heavily Friday on the New York Stock Exchange and the Nasdaq Stock Market:
FUEL: 9.77 (-0.19), NDLS: 18.23 (-0.63), ARIA: 8.13 (-0.04)
Seeking Alpha's Biotech Weekly: Sanofi's New Chief, Sarissa Shakes Ariad, And More
SA Editor Mike Taylor - Seeking Alpha - Fri Feb 20, 3:00PM CST
Every Friday, Seeking Alpha's Biotech Weekly highlights the editors' picks of the week's Seeking Alpha analysis, as well as a review of the top Breaking News stories. See something here that deserves further analysis? We are always looking for new...
BIIB: 409.59 (-0.51), BMRN: 107.07 (-1.77), CVM: 1.04 (+0.08), MDGN: 7.84 (-0.23), PFE: 34.32 (-0.27), SGMO: 16.82 (-0.15), RPRX: 9.21 (-0.28), MNKD: 6.52 (-0.30), CELG: 121.53 (-1.82), SGEN: 36.25 (-0.18), TEVA: 57.02 (+0.53), ARIA: 8.13 (-0.04), SNY: 48.86 (-0.01), REGN: 413.84 (-6.03)
Why Ariad Pharmaceuticals, Inc. Stock Soared Higher Today
Todd Campbell, The Motley Fool - Motley Fool - Fri Feb 20, 2:38PM CST
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis. What: After reporting fourth quarter and full...
ARIA: 8.13 (-0.04)
Ariad's largest shareholder starts proxy fight to oust CEO
Seeking Alpha - at Seeking Alpha - Fri Feb 20, 9:12AM CST
VVUS: 2.61 (-0.08), ARIA: 8.13 (-0.04)
Activist Hedge Fund Seeks Firing of Ariad Pharma CEO Berger
at The Street - Fri Feb 20, 6:09AM CST
Activist hedge fund Sarissa Capital is starting a proxy fight to force the ouster of Ariad Pharmaceuticals founder and CEO Harvey Berger.
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals (ARIA) Harvey J. Berger on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 19, 1:41PM CST
ARIA: 8.13 (-0.04)
Ariad Pharmaceuticals ups revenues 695% in Q4
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 8:22AM CST
ARIA: 8.13 (-0.04)
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 19, 8:05AM CST
ARIAD (ARIA) Posts Narrower-than-Expected Q4 Loss
ARIA: 8.13 (-0.04)
Ariad reports 4Q loss
Automated Insights - Thu Feb 19, 7:43AM CST
CAMBRIDGE, Mass. (AP) _ Ariad Pharmaceuticals Inc. (ARIA) on Thursday reported a loss of $5.8 million in its fourth quarter.
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals (ARIA) Q4 2014 Results - Earnings Call Webcast
SA Transcripts - at Seeking Alpha - Thu Feb 19, 7:25AM CST
ARIA: 8.13 (-0.04)
ARIAD Pharmaceuticals beats by $0.17, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 19, 6:39AM CST
ARIA: 8.13 (-0.04)
ARIAD Reports 2014 Financial Results, Provides 2015 Financial Guidance and Outlines Strategic Objectives
Business Wire - Thu Feb 19, 6:35AM CST
--Three New Iclusig Clinical Trials Planned to Begin This Year
ARIA: 8.13 (-0.04)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 18, 4:30PM CST
NBL: 47.23 (-0.09), TTC: 67.65 (+0.12), HST: 21.00 (-0.12), LXP: 10.83 (+0.12), UPL: 16.27 (+0.05), BBW: 21.67 (+0.72), WMT: 83.93 (+0.13), PDCO: 50.08 (+0.64), IDA: 62.62 (-0.22), CVRR: 19.46 (+0.94), DAN: 21.85 (-0.17), AYR: 23.07 (+0.13), DNR: 8.40 (+0.02), HII: 141.33 (-1.31), PWR: 28.78 (-0.08), GEL: 46.00 (+0.86), HRL: 58.51 (+0.05), MTRN: 36.62 (-0.32), UAN: 14.02 (+0.19), PCLN: 1,237.48 (-3.77), BCC: 35.61 (-0.25), ANIP: 67.36 (-2.10), NM: 4.35 (-0.24), SGNT: 27.18 (-1.16), IDCC: 52.87 (+0.19), BLMN: 25.76 (+0.40), PDCE: 51.68 (-1.99), DAVE: 30.72 (+0.06), WST: 54.72 (-0.23), TK: 44.24 (+0.17), VNDA: 10.76 (-0.28), CVI: 41.99 (+0.77), CLI: 18.81 (-0.17), CCC: 20.63 (-0.14), FCN: 36.87 (-0.26), IRC: 10.70 (+0.19), DTV: 88.60 (+0.25), AGI: 6.05 (-0.13), LINE: 12.02 (+0.06), SCG: 56.95 (-0.07), DISCA: 32.30 (-0.14), CBB: 3.35 (-0.01), IMAX: 34.97 (-0.04), RS: 57.01 (-0.53), SYNT: 49.40 (-0.23), DWRE: 63.19 (-1.36), FUN: 55.93 (+0.25), ATRO: 69.56 (+1.51), ARIA: 8.13 (-0.04), LPLA: 44.86 (-0.11), ACTA: 16.76 (+0.29), BRC: 26.96 (-0.22), GG: 21.98 (+0.24)
Will ARIAD (ARIA) Impress on Iclusig Sales this Earnings? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 18, 9:40AM CST
ARIAD Pharmaceuticals (ARIA) is set to report fourth-quarter 2014 results on Feb 19.
IPXL: 40.29 (-0.41), ISIS: 68.56 (+1.23), HZNP: 20.53 (+1.46), ARIA: 8.13 (-0.04)
(0)
(0)